المؤلفون: Al-Rubaish AM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al-Muhanna FA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Alshehri AM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al-Mansori MA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Alali RA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Khalil RM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al-Faraidy KA; Department of Cardiology, King Fahd Armed Forces Hospital, Dhahran, Saudi Arabia., Cyrus C; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Sulieman MM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Vatte C; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Loza BL; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Claassens DMF; Department of Cardiology, Isala Klinieken, Zwolle, the Netherlands., Asselbergs FW; Department of Cardiology, University Medical Center Utrecht, ICIN-Netherlands Heart Institute, Durrer Centre for Cardiogenetic Research, Utrecht, the Netherlands; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK., Al-Ali AK; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia. Electronic address: aalali@iau.edu.sa.

المصدر: International journal of cardiology [Int J Cardiol] 2022 Feb 01; Vol. 348, pp. 57. Date of Electronic Publication: 2021 Dec 09.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Percutaneous Coronary Intervention*/adverse effects , Platelet Aggregation Inhibitors*/adverse effects, Cytochrome P-450 CYP2C19/genetics ; Genotype ; Humans

المؤلفون: Al-Rubaish AM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al-Muhanna FA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Alshehri AM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al-Mansori MA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Alali RA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Khalil RM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Al Faraidy KA; Department of Cardiology, King Fahd Armed Forces Hospital, Dhahran, Saudi Arabia., Cyrus C; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Sulieman MM; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Vatte C; Department of Cardiology, King Fahd Armed Forces Hospital, Dhahran, Saudi Arabia., Claassens DMF; Department of Cardiology, Saint Antonius Hospital, Nieuwegein, The Netherlands., Ten Berg JM; Department of Cardiology, Saint Antonius Hospital, Nieuwegein, The Netherlands., Asselbergs FW; Department of Cardiology, University Medical Center Utrecht, ICIN-Netherlands Heart Institute, Durrer Centre for Cardiogenetic Research, Utrecht, The Netherlands.; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK., Al-Ali AK; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia. aalali@iau.edu.sa.

المصدر: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2020 Jun 03; Vol. 20 (1), pp. 268. Date of Electronic Publication: 2020 Jun 03.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE

مواضيع طبية MeSH: Percutaneous Coronary Intervention*/adverse effects , Percutaneous Coronary Intervention*/instrumentation , Pharmacogenomic Testing* , Pharmacogenomic Variants* , Point-of-Care Testing* , Polymorphism, Genetic*, Coronary Thrombosis/*prevention & control , Cytochrome P-450 CYP2C19/*genetics , Platelet Aggregation Inhibitors/*administration & dosage , ST Elevation Myocardial Infarction/*therapy, Clinical Decision-Making ; Clopidogrel/administration & dosage ; Coronary Thrombosis/etiology ; Humans ; Multicenter Studies as Topic ; Patient Selection ; Platelet Aggregation Inhibitors/adverse effects ; Prasugrel Hydrochloride/administration & dosage ; Predictive Value of Tests ; Prospective Studies ; Randomized Controlled Trials as Topic ; ST Elevation Myocardial Infarction/diagnosis ; ST Elevation Myocardial Infarction/genetics ; Saudi Arabia ; Stents ; Ticagrelor/administration & dosage ; Treatment Outcome